| For: | Cui JY, Ma J, Gao XX, Sheng ZM, Pan ZX, Shi LH, Zhang BG. Unraveling the role of cancer-associated fibroblasts in colorectal cancer. World J Gastrointest Oncol 2024; 16(12): 4565-4578 [PMID: 39678792 DOI: 10.4251/wjgo.v16.i12.4565] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i12/4565.htm |
| Number | Citing Articles |
| 1 |
Mathieu Reslinger, Michelina Plateroti. Stromal cells in normal colon and colon cancers: importance of thyroid hormone signaling. Cell Death & Disease 2025; 16(1) doi: 10.1038/s41419-025-08005-0
|
| 2 |
Paola Chiodelli, Andrea Papait, Lorenzo Agoni, Federico Quaglia, Antonietta Rosa Silini, Ornella Parolini. The tumor ecosystem: Rewiring an open, systemically integrated network for therapeutic gain. Biomedicine & Pharmacotherapy 2026; 195 doi: 10.1016/j.biopha.2026.119047
|
| 3 |
Sounik Manna, Angsuman Das Chaudhuri, Malay Dolai, Subhasis Das, Sujata Maiti Choudhury. Baicalein modulates colorectal tumor microenvironment to suppress growth, metastasis, and immune escape. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-025-11239-y
|
| 4 |
Maelle Picard, Arnaud Guille, Pascal Finetti, Bernadette De Rauglaudre, Nadiya Belfil, Lenaïg Mescam, David Jeremie Birnbaum, François Bertucci, Emilie Mamessier. Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value. Journal for ImmunoTherapy of Cancer 2026; 14(2) doi: 10.1136/jitc-2025-013356
|
| 5 |
Jia-Qi Zhang, Zhen-Duo Zhao, Xiao-Jing Qian, Qiao-Ling Zheng, Yi-Shi Cheng, Bo Cui, Xiao-Yu Zhuang, Jia-Hao Guo, Cheng Hu, Li-Chao Zhang. Aqueous extract of Solanum nigrum L. restrains colorectal cancer progression by blocking cancer-associated fibroblast-induced STAT3-Annexin A2 signaling. Phytomedicine 2026; 156 doi: 10.1016/j.phymed.2026.158257
|
| 6 |
Tianwei Chen, Yebin Yang, Jing Shi, Fanhe Dong, Lesi Xie, Yuqiang Shan, Xiang Wang. Multi-omics factor analysis identifies the Tensin 1-Fermitin family homologue 2–Fibronectin 1–Integrin signaling axis as a prognostic determinant in colorectal cancer. Molecular Biomedicine 2025; 6(1) doi: 10.1186/s43556-025-00386-0
|
| 7 |
Sree Priyanka Jeevanandan, Eileen Reidy, Julien Clegg, Rodrigo Curvello, Aideen E Ryan, Daniela Loessner. Advanced 3D cancer models for analyzing tumor-immune cell interaction and therapeutic response. Molecular Cancer 2026; 25(1) doi: 10.1186/s12943-026-02681-y
|
| 8 |
Chengyong Qian, Lingling Ren, Shuyuan Zhu, Fangling Chen, Haiping Shen, Xiangcheng Hu, Guanglan Chen. Current perspectives and trends in colorectal cancer and cancer-associated fibroblasts: a review and bibliometric analysis. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1618742
|
| 9 |
Abdelrahman Homedan, Darpan N. Pandya, Nicholas J. Schnicker, Thaddeus J. Wadas. Protein-based Radiopharmaceuticals that target fibroblast activation protein alpha: a review of current progress. EJNMMI Radiopharmacy and Chemistry 2025; 10(1) doi: 10.1186/s41181-025-00356-5
|
| 10 |
Ying Li, Dipanjan Chanda, Seong-Woo Jeon, Jae-Han Jeon, Min-Ji Kim. Mitochondrial Metabolic Reprogramming in Colorectal Cancer-Associated Fibroblasts: An Up-to-Date Review. Cancers 2026; 18(11) doi: 10.3390/cancers18111786
|
| 11 |
Faris Anad Muhammad, Abdulkareem Shareef, S. Renuka Jyothi, Priya Priyadarshini Nayak, J. Bethanney Janney, Gurjant Singh, Aashna Sinha, Nodira Rabbimova, Hayder Naji Sameer, Ahmed Yaseen, Rasim M. Salih, Mohaned Adil. Exosomal CeRNAs from the tumor microenvironment: hidden drivers of colorectal cancer progression. Journal of Molecular Histology 2026; 57(1) doi: 10.1007/s10735-026-10724-3
|
| 12 |
Ugne Silinskaite, Jurate Valciukiene, Matas Jakubauskas, Tomas Poskus. The Immune Environment in Colorectal Adenoma: A Systematic Review. Biomedicines 2025; 13(3) doi: 10.3390/biomedicines13030699
|
| 13 |
Mrunali Jayaprakash, Deekshit Vijaya Kumar, Gunimala Chakraborty, Anirban Chakraborty, Vinod Kumar. Bacteria-mediated cancer therapy (BMCT): Therapeutic applications, clinical insights, and the microbiome as an emerging hallmark of cancer. Biomedicine & Pharmacotherapy 2025; 192 doi: 10.1016/j.biopha.2025.118559
|